Navigation Links
Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
Date:7/16/2008

lopment programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release contains forward-looking statements regarding Sangamo's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable gene based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in the company's' Annual Reports on Form 10-K and Quarterly Repo
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
9. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
10. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ATTLE, Nov. 20 Cell Ther...ced today that the Ninth Circuit Court of Appeals ...t CTI should be allowed to pursue all of its claim... the District Court for trial. CTI filed a compla...ty reimbursement consultant for CTI,s product TRIS...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr...“The Role of Process Analytical Technology (...o; on December 1, 2009. , ... of Process Analytical Technology (PAT) in Green C...r 1, Process Analytical Technology (PAT) case stud...
(Date:11/19/2009)...GEN, Nov. 19 Danish Prince Joachim...c ethanol plant in Kalundborg, Denmark, on Wednesd...s first and largest 2nd generation ethanol demonst...es are used in the plant,s innovative process for ...Danisco, was the first to market with commercial e...
(Date:11/19/2009)...LT, N.Y., Nov. 19 Dr. Mate Hidvegi... responds to a press release issued on November 17...pany for making false and self-serving statements ..., Dr. Hidvegi stated from his office in Budapes...arch on Avemar does not apply to AveULTRA, www.a...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2
...ON, N.J., May 28 Quest Diagnostics scientists wil...ffect of genomic abnormalities on the diagnosis an...prostate cancer during the 45th Annual Meeting of ...scheduled for May 29 through June 2 in Orlando, FL... the world,s leading provider of diagnostic testin...
...AIN VIEW, Calif., May 28 Clontech Laboratories, I... today announced the upcoming (June 1, 2009) relea...n reagents. These novel transfection reagents are ...uperior transfection efficiency of plasmid DNA int...tions can be carried out entirely in the presence ...
...es to be presented on safety and efficacy of SpyGl...es throughout pancreatico-biliary system , , NATI...NYSE: BSX ) today announced that 14 abstracts an...SpyGlass(R) Direct Visualization System will be pr...runs from May 30 to June 4 in Chicago. , , "The ...
Other Biology Technology:Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 3Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 4Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 5Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 6
(Date:11/19/2009)...c diversity in maize, also known as corn, research...e map that should pave the way to significant impr..., fuel, animal feed and fiber around the world. ,... a haplotype map, charts genetic diversity and rec... maize. The research team, led by U.S. Department ...
(Date:11/19/2009)...09 -- Sustainable farming, initially adopted to pr...so play a role in maintaining a healthy climate, a...y,s Oak Ridge and Los Alamos national laboratories...arge potential of the earth,s soils to sequester c...ractices could greatly reduce U.S. carbon emission...
(Date:11/19/2009)... maize has identified thousands of diverse genes i... New techniques may allow breeders and researchers...le traits and create new varieties that were not e...19 issue of Science , the researchers, whose seni...d the first map of haplotypes sets of closely lin...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3New map of variation in maize genetics holds promise for developing new varieties 2Actuaries 3A Health Care Reform Must Address Costs 52038 1Actuaries 3A Health Care Reform Must Address Costs 52038 2MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 1MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 2MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 3MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 4Fetal Alcohol Disorders Often Misdiagnosed as ADHD 52030 1Fetal Alcohol Disorders Often Misdiagnosed as ADHD 52030 2
... LAFAYETTE, Ind. - A Purdue University researcher ...f the virus that causes SARS and could lead to a t... in 2003 led to hundreds of deaths and thousands o... said Arun Ghosh, the Purdue professor that led th...ntly a threat, there is the concern that SARS coul...
... LANSING, Mich. A Michigan State University resea...f cholesterol-lowering drugs may cause muscle prob...hat the effect statins can have on skeletal muscle...tion is underestimated, said Jill Slade, assistan...ive medicine at MSU. , "Statins work by preventin...
...ARBOR, Mich. It,s a leading cause of death, but n...a major source of health care costs, adding days o...f millions of people. But no one fully understands...tion in the blood, also called bacteremia, and it,...sepsis. , It,s an infection that will turn deadly...
Other Biology News:Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3MSU researcher studies ties between cholesterol drugs, muscle problems 2Battling bacteria in the blood: Researchers tackle deadly infections 2Battling bacteria in the blood: Researchers tackle deadly infections 3Battling bacteria in the blood: Researchers tackle deadly infections 4
Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Film Exposure Folders from Upstate
Biology Products: